536 related articles for article (PubMed ID: 28660562)
1. Continuous quantitative monitoring of physical activity in Parkinson's disease patients by using wearable devices: a case-control study.
Cai G; Huang Y; Luo S; Lin Z; Dai H; Ye Q
Neurol Sci; 2017 Sep; 38(9):1657-1663. PubMed ID: 28660562
[TBL] [Abstract][Full Text] [Related]
2. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
[TBL] [Abstract][Full Text] [Related]
3. Towards remote monitoring of Parkinson's disease tremor using wearable motion capture systems.
Delrobaei M; Memar S; Pieterman M; Stratton TW; McIsaac K; Jog M
J Neurol Sci; 2018 Jan; 384():38-45. PubMed ID: 29249375
[TBL] [Abstract][Full Text] [Related]
4. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
Goetz CG; Stebbins GT; Blasucci LM
Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
[TBL] [Abstract][Full Text] [Related]
5. Locomotor response to levodopa in fluctuating Parkinson's disease.
Moore ST; MacDougall HG; Gracies JM; Ondo WG
Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
[TBL] [Abstract][Full Text] [Related]
6. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
[TBL] [Abstract][Full Text] [Related]
7. Continuous Assessment of Levodopa Response in Parkinson's Disease Using Wearable Motion Sensors.
Pulliam CL; Heldman DA; Brokaw EB; Mera TO; Mari ZK; Burack MA
IEEE Trans Biomed Eng; 2018 Jan; 65(1):159-164. PubMed ID: 28459677
[TBL] [Abstract][Full Text] [Related]
8. Integrated robotics platform with haptic control differentiates subjects with Parkinson's disease from controls and quantifies the motor effects of levodopa.
Gaprielian P; Scott SH; Lowrey C; Reid S; Pari G; Levy R
J Neuroeng Rehabil; 2019 Oct; 16(1):124. PubMed ID: 31655612
[TBL] [Abstract][Full Text] [Related]
9. Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.
Senek M; Aquilonius SM; Askmark H; Bergquist F; Constantinescu R; Ericsson A; Lycke S; Medvedev A; Memedi M; Ohlsson F; Spira J; Westin J; Nyholm D
Eur J Clin Pharmacol; 2017 May; 73(5):563-571. PubMed ID: 28101657
[TBL] [Abstract][Full Text] [Related]
10. Clinical feasibility of a wearable, conformable sensor patch to monitor motor symptoms in Parkinson's disease.
Boroojerdi B; Ghaffari R; Mahadevan N; Markowitz M; Melton K; Morey B; Otoul C; Patel S; Phillips J; Sen-Gupta E; Stumpp O; Tatla D; Terricabras D; Claes K; Wright JA; Sheth N
Parkinsonism Relat Disord; 2019 Apr; 61():70-76. PubMed ID: 30635244
[TBL] [Abstract][Full Text] [Related]
11. UPDRS activity of daily living score as a marker of Parkinson's disease progression.
Harrison MB; Wylie SA; Frysinger RC; Patrie JT; Huss DS; Currie LJ; Wooten GF
Mov Disord; 2009 Jan; 24(2):224-30. PubMed ID: 18951537
[TBL] [Abstract][Full Text] [Related]
12. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
[TBL] [Abstract][Full Text] [Related]
13. Lifecorder: a new device for the long-term monitoring of motor activities for Parkinson's disease.
Saito N; Yamamoto T; Sugiura Y; Shimizu S; Shimizu M
Intern Med; 2004 Aug; 43(8):685-92. PubMed ID: 15468966
[TBL] [Abstract][Full Text] [Related]
14. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
Fahn S;
J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
[TBL] [Abstract][Full Text] [Related]
15. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
[TBL] [Abstract][Full Text] [Related]
16. Impact of motor fluctuations on real-life gait in Parkinson's patients.
Silva de Lima AL; Evers LJW; Hahn T; de Vries NM; Daeschler M; Boroojerdi B; Terricabras D; Little MA; Bloem BR; Faber MJ
Gait Posture; 2018 May; 62():388-394. PubMed ID: 29627498
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory surface electromyography with accelerometry for evaluating daily motor fluctuations in Parkinson's disease.
Rissanen SM; Koivu M; Hartikainen P; Pekkonen E
Clin Neurophysiol; 2021 Feb; 132(2):469-479. PubMed ID: 33450567
[TBL] [Abstract][Full Text] [Related]
18. Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease.
Uchino K; Shiraishi M; Tanaka K; Akamatsu M; Hasegawa Y
PLoS One; 2017; 12(11):e0187616. PubMed ID: 29121638
[TBL] [Abstract][Full Text] [Related]
19. Do patients with late-stage Parkinson's disease still respond to levodopa?
Fabbri M; Coelho M; Abreu D; Guedes LC; Rosa MM; Costa N; Antonini A; Ferreira JJ
Parkinsonism Relat Disord; 2016 May; 26():10-6. PubMed ID: 26972527
[TBL] [Abstract][Full Text] [Related]
20. Profiling the most elderly parkinson's disease patients: Does age or disease duration matter?
Virameteekul S; Phokaewvarangkul O; Bhidayasiri R
PLoS One; 2021; 16(12):e0261302. PubMed ID: 34937068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
